What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective.
Título
What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective.
Autor
Yinglian Hu, Simiao Chen
Fecha
2021
Identificador
10.1093/jtm/taab026
Fuente
Journal of travel medicine
Colección
Citación
Yinglian Hu, Simiao Chen, “What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective.,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/8867.
Position: 8685 (27 views)